@article {2260, title = {Anxiety Levels, Cortisol, Blood Gluc Ose and Sodium Levels in Working Wives: Comparison Between Husbands Who Were Hospitalized and Husbands Who Were Not Hospitalized}, journal = {Pharmacognosy Journal}, volume = {16}, year = {2024}, month = {April 2024}, pages = {382-387}, type = {Research Article}, chapter = {382}, abstract = {

Background:\ Anxiety affects balance and physiological changes in the body. The research aims to investigate the comparison of anxiety levels, blood cortisol levels, blood glucose levels and blood sodium levels between working wives of husbands who are hospitalized and working wives of husbands who are not hospitalized. Methods: The research design uses statistical group comparison. The research subjects were 40 people divided into 2 groups, namely 20 subjects, working wives, husbands who were hospitalized, 20 subjects, working wives, husbands, who were not hospitalized. Data was collected using the HARS (Hamilton Anxiety Rating Scale) questionnaire instrument, laboratory examination of blood cortisol levels, blood glucose levels and blood sodium levels. Results: Unpaired t test with a significant value of p \< 0.05 if the data is normally distributed or Mann Whitney U Test with a significant value of p \< 0.05 if the data is not normally distributed was carried out to analyze the comparison of anxiety levels, blood cortisol levels, sugar levels blood and blood sodium levels. Data processing with the help of statistical software. The results of the analysis showed that there were differences in anxiety levels (p\<0.05), blood cortisol levels (p\<0.05) and blood glucose levels (p\<0.05) but there were no differences in blood sodium levels (p\>0.05). between working wives whose husbands are hospitalized and working wives whose husbands are not hospitalized. Conclusion: blood cortisol levels and blood sugar levels in working wives of husbands who were hospitalized were higher than working wives of husbands who were not hospitalized and based on statistical tests, significant differences were found in HARS values, blood cortisol levels and blood sugar levels between the group of working wives whose husbands were hospitalized. hospitalized and the wife works, the husband is not hospitalized.

}, keywords = {Anxiety, blood cortisol levels, blood glucose levels, blood sodium levels, HARS, working wife}, doi = {10.5530/pj.2024.16.59}, author = {Rudi Mahruzar and I Nyoman Ehrich Lister and OK Yulizal and Hamzah Shatri and Gusbakti Rusip} } @article {2214, title = {Evaluating the Therapeutic Potential of Vernonia amygdalina: A Promising Antidiabetic Agent in STZ and Nicotinamide-Induced Rat Model}, journal = {Pharmacognosy Journal}, volume = {16}, year = {2024}, month = {February 2024}, pages = {94-99}, type = {Original Article}, chapter = {94}, abstract = {

Background: Vernonia amygdalina, commonly known as bitter leaf, has been traditionally used for its potential antidiabetic properties. This study aimed to evaluate the therapeutic potential of Vernonia amygdalina extract (VAE) in ameliorating hyperglycemia using a streptozotocin (STZ) and high-fat diet (HFD)-induced rat model of diabetes. Methods: Sixty male Wistar rats were divided into six groups: normal control, diabetic control, and four treatment groups receiving different doses of VAE (100, 300, and 500 mg/kg body weight) orally for eight weeks. Diabetes was induced in rats by a single intraperitoneal injection of STZ (55 mg/kg) after four weeks of Nicotinamid feeding. Body weight, fasting blood glucose levels, HbA1c, serum insulin levels, superoxide dismutase (SOD) activity, and malondialdehyde (MDA) levels were measured. Results: Treatment with VAE significantly reduced fasting blood glucose levels in a dose-dependent manner compared to the diabetic control group (p \< 0.05). VAE administration also led to a significant decrease in HbA1c levels and an increase in serum insulin levels in a dosedependent manner (p \< 0.05). Furthermore, VAE supplementation restored SOD activity and reduced MDA levels, indicating improved antioxidant status in the treated groups (p \< 0.05). Conclusion: This study demonstrates the therapeutic potential of Vernonia amygdalina as an antidiabetic agent in the STZ and HFD-induced rat model of diabetes. VAE supplementation effectively reduced fasting blood glucose levels, improved glycemic control as indicated by reduced HbA1c levels, and enhanced insulin secretion. Moreover, VAE exhibited antioxidant activity by restoring SOD activity and reducing MDA levels. These findings suggest that Vernonia amygdalina could be a promising natural remedy for the management of diabetes. Further investigations are warranted to elucidate the underlying mechanisms and evaluate its long-term safety and efficacy in humans.

}, keywords = {Diabetes, HbA1c, Insulin, MDA, SOD, Vernonia amygdalina}, doi = {10.5530/pj.2024.16.13}, author = {Muhammad Faridz Syahrian and I Nyoman Ehrich Lister and Chrismis Novalinda Ginting} }